Close Menu

NEW YORK  — Chronic disease laboratory company Salveo Diagnostics this week announced its acquisition of autoimmune-focused diagnostics firm ImmunArray and health engagement platform Nudge.

Financial and other terms of the deal were not released.

The firms said the merger will expand Salveo's testing abilities and improve communication between providers and patients while also allowing patients to access lab results on their smartphones.

All three companies are based in Richmond, Virginia. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
07
Sponsored by
Beckman Coulter

This webinar will discuss strategies for urinary tract infection (UTI) testing with the focus of detecting avoidable urine cultures.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center  has implemented a new capture-based application to accurately assess myeloid malignancies   by detecting complex variants in challenging genes  in a single experiment.